EU companies can export generic versions of patented drugs to poor countriesBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7550.1112-a (Published 11 May 2006) Cite this as: BMJ 2006;332:1112
- Rory Watson
The European Union has adopted legislation that will allow companies to produce copies of patented medicines, under licence, for export to developing countries. The measures will allow poor nations that lack or have insufficient drug manufacturing capacity, to import safe and effective generic medicines.
The initiative follows the move last December by the Geneva based World Trade Organisation (WTO) to make permanent an earlier provisional waiver to the trade related aspects of intellectual property rights (TRIPS) agreement.
This amends the existing rules on intellectual property, which state that compulsory licences can only be …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial